Medtech: Rapid Cost-Freeing
Scenario: High R&D and supply chain costs limiting investment in growth.
Actions: Applied zero-based budgeting, redesigned cost base, and automated support functions.
Result: USD 300M+ freed in savings—capital reallocated to accelerate innovation.

